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State of the art immunogenetics and immunoinformatics 
Antibodies, or immunoglobulins, belong to the 
‘gamma globulin’ protein group and can be found 
mainly in the blood of vertebrates. Antibodies 
constitute the major serological line of defense of the 
vertebrates with jaws (gnathostomata) by which the 
immune system identifies and neutralizes threatening 
invaders, such as viruses, fungi, parasites, bacteria. 
The contrivance underlying the reaction efficiency of 
our immune system to specifically recognize and fight 
invading organisms or to trigger an autoimmune 
response and disease still remains to be elucidated. 
 The efficient reaction of our immune 
system against all kinds of intruders is highly 
dependent on the number, condition and 
availability of antibodies, as reaction times are 
‘key’ to the successful elimination of the foreign 
pathogen (Filntisi et al. 2013). In reference to 
autoimmune diseases, antibodies can be described 
as an inappropriate and offensive response of the 
immune system against normal tissues of the body. 
In essence the immune system mistakenly 
recognizes its own cells as potential pathogens and 
attacks them (Filntisi et al. 2013). In most cases 
this reaction may be localized on just parts of 
certain organs or include a specific type of tissue 
that can be found in more than one organ in the 
human body. Up until now, the most commonly 
practiced clinical treatments for diseases of the 
immune system involve immunosuppression, 
which aims to lessen the reactive immune 
response. 
 IMGT/3Dstructure-DB in one of the largest 
open-source structure related databases available 
and together with its query, has a great appeal on 
immunogenetics and immunoinformatics. The 
database is active and updated frequently. The 
query tool for the database is also updated 
frequently (version 4.10.0, 2014-04-09). The 
IMGT/3Dstructure-DB query tool can seek data 
among the 5439 entries of the database, but can 
also seek data from three other external databases. 
First and foremost, from the Protein Data Bank 
(PDB), which hosts 4596 entries, moreover, from 
the World Health Organization’s Non Proprietary 
Names (WHO/INN) database, which hosts 507 
entries and last but not least, from the Kabat 
Sequence Database, which hosts 336 entries. In 
spite of having such large quantity of information, 
which makes it not so user-friendly for the novice 
user, it will reward the professional user with its 
detailed and precise adjustability of every different 
inquiry needed (Ehrenmann & Lefranc 2011). The 
criteria of the inquiry can be set separately or can 
be combined diminishing the results. 
IMGT/3Dstructure-DB allows searching the 
database by specific structural characteristics, by 
experimental data or bibliographical references, by 
molecule name or entry code. In addition, the 
query tool of the IMGT/3Dstructure-DB can 
search for structures with criteria such as the 
complex type (selecting between: IG/Ag, TR/
pMH1, TR/pMH2, RPI/pMH1, RPI/pMH2, pMH1 
and pMH2), the local structure at position, 
specifying the presence of a specific amino acid, 
the type of the secondary structure, amino acid φ 
and ψ angles in degrees, the accessible surface 
area (ASA) in angstrom2 (Å2) and the type of atom 
contacts between two positions (Giudicelli  et al. 
2005). 
 As mentioned above, currently there are 
4596 antibody structures that are expertly 
annotated in IMGT/3Dstructure-DB, with gene 
and allele identification, CDR-IMGT lengths, 
contact analysis. These are all X-ray 
crystallography, NMR or electron microscopy 
determined three dimensional structures of 
antibodies (Vlachakis et al. 2014a). A set of in-
house developed filters and tools were applied to 
select and identify the best candidate template 
structure of each of the aforementioned groups of 
antibodies (Vlachakis et al. 2014b, c). The filters 
were mainly based on the simultaneous 
satisfaction of the exact CDR length required for 
each group, the percentage coverage, percentage 
identity and similarity score (Maltezos et al. 2014). 
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The IMGT curated database of the 3D structures of 
antibodies has been optimized to include keys or 
metadata for the description of a series of crucial 
antibody characteristics (Filntisi et al. 2013). Some 
of them include the number of chains in the PDB 
entry, the resolution of the X-ray crystallography, 
the date it was released, the species (Homo 
sapiens, Mus musculus), the variable domain type 
(e.g. VH or VL, and for VL, V-KAPPA, V-
LAMBDA), and for those that are dimers, a 
description of their dimeric type (e.g. VH:VL).  
 From the user’s point of view, the query 
tool for the IMGT/3Dstructure-DB as a GUI 
(Graphical User Interface) is lacking of 
adaptability to each specified query processes, 
making it more difficult to understand how it is 
operated. While for example, at the HIV Molecular 
Immunology Database we can see how easily the 
graphical interface is adapted to the inquiry taking 
place (Filntisi et al. 2013). Moreover, it could be 
improved in the aspects of practicality, for 
example having a quick search tool, like the 
AbMiner database (Major et al. 2006). In addition, 
the graphical interface could enhance the ease of 
use and learning of the tool, guiding the user step-
by-step, like the pop-up boxes the Abysis query 
tool has (Swindells et al. 2017). 
 In conclusion, the IMGT/3Dstructure-DB 
is a powerful tool to search and obtain information 
about the appropriate antibody structures. 
Combined with IMGT/DomainGapAlign and 
IMGT/Collier-de-Perles tool, which are also freely 
available, they greatly contribute to the 
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